Organika Health Products Goutrin capsules
Organika Health Products Goutrin capsules, NPN 80034655: natural health product licensed in Canada. Medicinal ingredients: Mentha piperita, Apium graveolens, Thymus vulgaris, Acide ascorbique.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mentha piperita Source : Feuille Extraction ratio : 15:1 Dry plant equivalent : 900 mg | 60 mg | Not calculated |
| Apium graveolens Source : Graine(s) | 100 mg | Not calculated |
| Thymus vulgaris Source : Feuille | 100 mg | Not calculated |
| Acide ascorbique Source : Ascorbate de calcium | 30 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 3 Tous les jours |
Uses authorised in Canada
Celery seed is traditionally used in herbal medicine to relieve the pain associated with gout. Source of Vitamin C for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner prior to use if you have diabetes or a renal disorder. Consult a health care practitioner prior to use if you have anemia. Consult a health care practitioner prior to use if you have gallstones. Consult a health care practitioner if symptoms persist or worsen.
- Contra-Indications
Do not use if you are pregnant or breastfeeding. Do not use if you are allergic to plants in the Apiaceae/Umbelliferae family. Discontinue use if allergic reaction occurs. Discontinue use if gastrointestinal problems occur.
- Known Adverse Reactions
Celery seed may increase UV light sensitivity; limit excess exposure to ultraviolet rays (e.g. sunbathing or tanning salons) for prolonged periods while using this product.
Product record
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80034655
- Status
- Active licence
- Licence date
- 15 August 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80034655
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Mentha piperita
Read the warning, when it applies and the studies cited
PEPPERMINT - MENTHA X PIPERITA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Condition of application: Essential oil.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Condition of application: Essential oil.
When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (3)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).
Sources cited by Health Canada (2)
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- Thymus vulgaris
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Products Goutrin capsules: composition and ingredients”, https://compoatlas.com/en/supplements/canada/80034655-organika-health-products-goutrin-capsules, updated 15 August 2012.